ADCT - ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Transcript
2025-08-12 11:27:54 ET
ADC Therapeutics SA (ADCT)
Q2 2025 Earnings Conference Call
August 12 2025, 08:30 AM ET
Company Participants
Ameet Mallik - CEO & Director
Jose I. Carmona - Chief Financial Officer
Mohamed Zaki - Chief Medical Officer
Nicole Riley - Corporate Participant
Conference Call Participants
Eric Thomas Schmidt - Cantor Fitzgerald & Co., Research Division
Jenna Li - Jefferies LLC, Research Division
Leonid Timashev - RBC Capital Markets, Research Division
Michael Werner Schmidt - Guggenheim Securities, LLC, Research Division
Sudan Naveen Loganathan - Stephens Inc., Research Division
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics SA ADCT Q2 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Tuesday, August 12, 2025.
I will now turn the call over to Nicole Riley, Head of Investor Relations and Corporate Communications for ADC Therapeutics. Nicole, please go ahead....
ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Transcript